Cronos group inc. CRON.US Overview

BetaUS StockHealthcare
(No presentation for CRON)

CRON AI Analysis & Strategy

Analysis Conclusion

The stock has been awarded the top rating for its value, but its dividend score is below 2. If the company starts distributing dividends, it may yield even better investment results.

CRON Current Performance

-2.62%

Cronos group inc.

-0.35%

Avg of Sector

-0.22%

S&P500

CRON Key Information

CRON Financial Forecast

Unit : USD

CRON Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
0.02
300%
-300%
22.55M
-10.4%
-48.8%
106.2%
2024Q3
-0.01
80%
0%
28.62M
16.4%
-41.2%
24.4%
2024Q2
-0.02
-364%
300%
34.26M
1%
-29.6%
-31.5%
2024Q1
-0.02
0%
700%
27.76M
45.9%
6.3%
-8.9%
2023Q4
-0.01
66.7%
25%
25.18M
25%
5.9%
-187.3%

CRON Profile

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Price of CRON